Ind-Swift spurts on unveiling generic formulation of Atorvastation in UK

17 May 2012 Evaluate

Ind-Swift is currently trading at Rs. 26.40, up by 0.60 points or 2.33% from its previous closing of Rs. 25.80 on the BSE.

The scrip opened at Rs. 26.45 and has touched a high and low of Rs. 27.30 and Rs. 26.00 respectively. So far 34267 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 34.90 on 15-Sep-2011 and a 52 week low of Rs. 23.15 on 02-Jan-2012.

Last one week high and low of the scrip stood at Rs. 27.95 and Rs. 25.60 respectively. The current market cap of the company is Rs. 120.53 crore.

The promoters holding in the company stood at 48.48% while Institutions and Non-Institutions held 3.69% and 47.82% respectively.

Ind-Swift has launched generic formulation of the world’s best selling drug -- Atorvastation -- in UK in collaboration with Wockhardt UK on the first day of its patent expiry. Atorvastation is the world’s best selling drug with the world market size of $16 billion.

The drug went off patent in Europe on May 6, 2012 and taking this opportunity Ind Swift and its EU marketing partner Wockhardt UK launched the generic vwersion of the molecule in UK on the day after its patent expiry.

The product was launched in all its strengths i.e. 10mg, 40mg and 80mg.

Ind-Swift is a fully integrated pharma group. The API required for the product was supplied from the USFDA and MHRA approved plant of Ind-Swif Laboratories and the formulations was manufactured and supplied from the 100% export facility of Ind-Swift located near Derabassi Punjab.

Ind-Swift - Amalgama Share Price

15.70 0.00 (0.00%)
13-Aug-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×